Patient info Search Menu

Teetha Teething Gel – Summary of Product Characteristics (SmPC) for healthcare professionals

Updated:

Summary of Product Characteristics (SmPC) - Teetha Teething gel

1 NAME OF THE MEDICINAL PRODUCT

Teetha Teething Gel

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Chamomilla recutita 12c

For full list of excipients, see section 6.1.

3 PHARMACEUTICAL FORM

Oral gel.

Colourless translucent gel.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

A homeopathic medicinal product used within the homeopathic tradition for the symptomatic relief of teething pain and the symptoms associated with teething which are sore & tender gums, flushed cheeks and dribbling.

4.2 Posology and method of administration

For babies aged 3 months and over.

With a clean finger apply a pea sized amount of gel to the sore area on the baby’s gums and teeth.

Use every 4 hours for up to 6 times a day.

This product is not recommended for use in babies under 3 months old.

If symptoms worsen or persist after 7 days of using this product, a doctor or qualified healthcare practitioner should be consulted.

4.3 Contraindications

Hypersensitivity to Chamomilla preparations or any of the excipients.

4.4 Special warnings and precautions for use

This medicine contains 21 mg of alcohol (ethanol) in each dose which is equivalent to 3.8 mg ethanol/kg body weight. The amount in one dose of this medicine is equivalent to less than 0.5 ml beer or 0.2 ml wine. The small amount of alcohol in this medicine will not have any noticeable effects.

The use of this product with other medicinal products containing ethanol should be avoided.

Do not use if seal is broken.

A doctor or a qualified healthcare practitioner should be consulted if symptoms worsen or persist for more than 7 days.

4.5 Interaction with other medicinal products and other forms of interaction

None known.

4.6 Fertility, pregnancy and lactation

The use of this product in pregnancy and lactation is not applicable. However, if use in pregnancy and lactation is required, the advice of a doctor should be sought.

Studies on the effects on fertility have not been performed

4.7 Effects on ability to drive and use machines

None known.

4.8 Undesirable effects

There are no known adverse effects. If any adverse effects are experienced, a doctor or pharmacist should be consulted.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9 Overdose

None known. Overdose with this medicine is unlikely to constitute a hazard and therefore symptomatic treatment only is necessary.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Not applicable.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

Not applicable

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Water

Glycerol (E422)

Xanthan gum

Xylitol (E967)

Hypromellose

Ethanol

6.2 Incompatibilities

None known.

6.3 Shelf life

24 months

Once opened use within 28 days of opening.

6.4 Special precautions for storage

Do not store above 250C.

6.5 Nature and contents of container

Pack size 15g.

Collapsible, sealed aluminium tube with a polypropylene cap incorporating a tamper evident seal and a piercing device used to pierce the tube seal.

6.6 Special precautions for disposal

Pierce tube seal with point in top of cap before first use.

Apply with a clean finger to babies/children’s gums and teeth.

7 MARKETING AUTHORISATION HOLDER

A Nelson & Co Limited

5-9 Endeavour Way

Wimbledon

London

SW19 8UH

8 MARKETING AUTHORISATION NUMBER(S)

NR 01175/0184

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

24/05/2012

10 DATE OF REVISION OF THE TEXT

27/01/2022

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: NR011750184

Last revision stated in the text: 27 January 2022 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Teetha Teething gel

What these facts mean

Pharmaceutical form? Colourless translucent gel.
Excipients? Water, Glycerol (E422), Xanthan gum, Xylitol (E967), Hypromellose, Ethanol
Shelf life? 24 months
Once opened use within 28 days of opening.
Storage Do not store above 25°C.
Marketing authorisation? NR 01175/0184 (first authorised 24 May 2012)
Marketing authorisation holder? A Nelson & Co Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.